Brief: Adaptimmune Unit Receives Termination Notice Of Strategic Collaboration, License Agreement With Genentech

Adaptimmune Therapeutics

12/04/2024 15:22

April 12 (Reuters) - Adaptimmune Therapeutics PLC
 ADAP.O :
    * ADAPTIMMUNE THERAPEUTICS : ON APRIL 10,  UNIT OF CO,
RECEIVED
NOTICE OF TERMINATION OF STRATEGIC COLLABORATION AND LICENSE
AGREEMENT WITH GENENTECH
    * ADAPTIMMUNE THERAPEUTICS PLC: TERMINATION WILL BECOME
EFFECTIVE
180 DAYS AFTER DATE OF RECEIPT OF NOTICE OF TERMINATION
    * ADAPTIMMUNE THERAPEUTICS PLC: AS A RESULT OF TERMINATION,
CO NOT
ENTITLED TO RECEIVE FURTHER MILESTONES OR OTHER PAYMENTS DUE
AFTER TERMINATION DATE
    * ADAPTIMMUNE THERAPEUTICS PLC: WILL ALSO CEASE TO HAVE ANY
DEVELOPMENT OBLIGATIONS AFTER TERMINATION DATE

Source text for Eikon:  ID:n0001558370-24-004997 
Further company coverage:  ADAP.O 

 ((Reuters.Briefs@thomsonreuters.com;))